Page 4 - Vaccine Transition Option News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vaccine transition option. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vaccine Transition Option Today - Breaking & Trending Today

Pfizer Offers Covid Shots to Health-Care Workers Who Got Placebo

Pfizer Offers Covid Shots to Health Workers Who Got Placebo
Bloomberg
12/16/2020
Riley Griffin and John Lauerman
© Bloomberg
A heath worker injects the Gam-COVID-Vac , also known as Sputnik V , COVID-19 vaccine, developed by the Gamaleya National Research Center for Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF), into a patients arm during a post-registration phase trial at the City Clinic #46 in Moscow, Russia, on Wednesday, Sept. 23, 2020. The Russian Direct Investment Fund will sell 32 million doses of Sputnik V to Mexico, with deliveries starting in November, the sovereign wealth fund said in a statement.
(Bloomberg) Health-care workers given a placebo in the Pfizer Inc.-BioNTech SE vaccine trial are already getting access to the newly authorized shot. ....

United States , John Vanchiere , Yasir Batalvi , Gamaleya National Research Center , Drug Administration , Russian Direct Investment Fund , Pfizer Inc , Louisiana State University Health Shreveport , Moderna Inc , City Clinic , Vaccine Transition Option , Louisiana State University Health , ஒன்றுபட்டது மாநிலங்களில் , யாசிர் புதல்வி , ரஷ்ய நேரடி முதலீடு நிதி , ஃபைசர் இன்க் , லூசியானா நிலை பல்கலைக்கழகம் ஆரோக்கியம் ஷ்ரெவெப்போருத , மாடர்னா இன்க் , நகரம் சிகிச்சையகம் , தடுப்பூசி மாற்றம் விருப்பம் , லூசியானா நிலை பல்கலைக்கழகம் ஆரோக்கியம் ,

Pfizer offers Covid-19 shots to health-care workers who got placebo

Previous to Holiday
Vanchiere plans to vaccinate the rest of the eligible and interested placebo-group participants before the upcoming holiday. The trial site has 20 appointment slots available a day.
Placebo groups provide a critical point of comparison in gold-standard clinical trials, allowing researchers to study long-term side effects over time.
Over the last few months, however, U.S. regulators, drugmakers, and trial participants have engaged in an ethical debate over whether or not to provide protection to all those who joined the clinical trial. Ultimately, offering broader protection amid a nationwide surge in cases has trumped pleas to maintain the integrity of such long-term safety data. ....

United States , Andrey Rudakov Bloomberg , John Vanchiere , Yasir Batalvi , Louisiana State University Health Shreveport , Pfizer Inc , Moderna Inc , Drug Administration , New York , Vaccine Transition Option , Louisiana State University Health , ஒன்றுபட்டது மாநிலங்களில் , யாசிர் புதல்வி , லூசியானா நிலை பல்கலைக்கழகம் ஆரோக்கியம் ஷ்ரெவெப்போருத , ஃபைசர் இன்க் , மாடர்னா இன்க் , புதியது யார்க் , தடுப்பூசி மாற்றம் விருப்பம் , லூசியானா நிலை பல்கலைக்கழகம் ஆரோக்கியம் ,